Effects of shunting CSF in superficial siderosis of the CNS.
McCarron
Mark O
MO
Department of Neurology, Royal Victoria Hospital, Belfast, UK. markmccarron@doctors.org.uk
Patterson
Victor H
VH
D001254:Astrocytoma / Q000532:radiotherapy / Q000601:surgery*; D001259:Ataxia / Q000150:complications / Q000175:diagnosis; D001663:Bilirubin / Q000134:cerebrospinal fluid; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D001933:Brain Stem / Q000473:pathology; D002493:Central Nervous System Diseases / Q000150:complications / Q000601:surgery*; D002531:Cerebellum / Q000473:pathology; D002555:Cerebrospinal Fluid / Q000737:chemistry; D002557:Cerebrospinal Fluid Shunts; D002648:Child; D004185:Disability Evaluation; D005074:Evoked Potentials, Visual; D005293:Ferritins / Q000134:cerebrospinal fluid; D006311:Hearing Disorders / Q000150:complications / Q000175:diagnosis; D006485:Hemosiderin / Q000134:cerebrospinal fluid; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012806:Siderosis / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D013995:Time; D016896:Treatment Outcome
D005293:Ferritins; D006485:Hemosiderin; D001663:Bilirubin